Autobio Diagnostics Co., Ltd. Stock price

Equities

603658

CNE100002GC4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-02-28 pm EST 5-day change 1st Jan Change
66.36 CNY +6.18% Intraday chart for Autobio Diagnostics Co., Ltd. +13.53% +16.40%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2023 * 4.57B 635M Sales 2024 * 5.68B 790M Capitalization 38.56B 5.36B
Net income 2023 * 1.25B 174M Net income 2024 * 1.56B 217M EV / Sales 2023 * 8.27 x
Net cash position 2023 * 762M 106M Net cash position 2024 * 1.1B 153M EV / Sales 2024 * 6.59 x
P/E ratio 2023 *
30.5 x
P/E ratio 2024 *
24.9 x
Employees 5,505
Yield 2023 *
1.41%
Yield 2024 *
1.7%
Free-Float 31.25%
More Fundamentals * Assessed data
Dynamic Chart
Autobio Diagnostics Gets Regulatory Nod in China for 16 Devices MT
Autobio Diagnostics Co., Ltd. announces an Equity Buyback for CNY 500 million worth of its shares. CI
Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan. CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to S&P Global BMI Index CI
Autobio Diagnostics Logs Low Single-Digit Earnings Growth in H1 MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Autobio Diagnostics Gets Registration Certificates for Five Devices MT
Shenzhen Meili Namikong Technology Co., Ltd. announced that it has received funding from Autobio Diagnostics Co., Ltd. CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to FTSE All-World Index CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022. CI
Autobio Diagnostics Co., Ltd.'s Equity Buyback announced on March 19, 2022, has closed with 5,260,910 shares, representing 0.90% for CNY 243.27 million. CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022. CI
More news
1 day+6.18%
1 week+13.53%
1 month+40.98%
3 months+29.23%
6 months+44.73%
Current year+16.40%
More quotes
1 week
57.93
Extreme 57.93
66.36
1 month
47.22
Extreme 47.22
66.36
Current year
45.60
Extreme 45.6
66.36
1 year
41.01
Extreme 41.01
66.36
3 years
40.70
Extreme 40.7
96.85
5 years
40.70
Extreme 40.7
139.22
10 years
13.46
Extreme 13.4615
139.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 02-12-31
Director of Finance/CFO 46 02-12-31
Chairman 57 02-12-31
Members of the board TitleAgeSince
Director/Board Member 60 18-10-28
Chairman 57 02-12-31
Director/Board Member 59 05-12-31
More insiders
Date Price Change Volume
24-02-29 66.36 +6.18% 5,691,797
24-02-28 62.5 +4.62% 5,787,238
24-02-27 59.74 -0.43% 2,503,514
24-02-26 60 +2.56% 2,760,107
24-02-23 58.5 +0.09% 2,474,779

End-of-day quote Shanghai S.E., February 28, 2024

More quotes
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
66.36 CNY
Average target price
59.49 CNY
Spread / Average Target
-10.35%
Consensus
  1. Stock
  2. Equities
  3. Stock Autobio Diagnostics Co., Ltd. - Shanghai S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW